Medivate Partners

Medivate Partners operates as a private equity and venture capital firm, specializing in strategic investments within the biotech and healthcare sectors. The firm identifies and supports innovative companies developing essential technologies and infrastructure for human health. It leverages cross-border opportunities, primarily between Asia and North America, to drive impactful growth and foster global healthcare innovation.

Established in 2012, Medivate Partners arose from a clear understanding of the global healthcare market's investment potential and the advantages of international collaborations. While its specific founders are not publicly detailed, its successor, Forward Equity Partners, is led by experienced industry veterans, including Paul H. Kim, CEO and Managing Partner, and Hong Jun Park, a Managing Partner.

The firm targets companies within healthcare and life science, offering capital and strategic guidance. Medivate Partners' vision is to cultivate a portfolio of medical innovations that significantly contribute to human health. Its approach continually advances the global healthcare landscape.